U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C6H11O7.Cu
Molecular Weight 453.841
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COPPER GLUCONATE

SMILES

[Cu++].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O

InChI

InChIKey=OCUCCJIRFHNWBP-IYEMJOQQSA-L
InChI=1S/2C6H12O7.Cu/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1

HIDE SMILES / InChI

Molecular Formula Cu
Molecular Weight 63.546
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H11O7
Molecular Weight 195.1473
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Sources: http://fs1.agrian.com/pdfs/CORE_7.5_Copper_EDTA_Label.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/24106015 | https://www.ncbi.nlm.nih.gov/pubmed/20942456http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500013010.pdfhttp://www.drugfuture.com/chemdata/tetraamminecopper-sulfate.html | https://cameochemicals.noaa.gov/chemical/3026https://www.ncbi.nlm.nih.gov/pubmed/6526221https://www.ncbi.nlm.nih.gov/pubmed/16971307https://www3.epa.gov/pesticides/chem_search/ppls/019713-00509-20110705.pdfhttps://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=522.518 | http://www.worldofchemicals.com/chemicals/chemical-properties/cupric-glycinate.htmlDOI: 10.1107/s0567740869001725 Retrived from http://scripts.iucr.org/cgi-bin/paper?S0567740869001725https://www.ncbi.nlm.nih.gov/pubmed/15704330 | https://www.ncbi.nlm.nih.gov/pubmed/12425037 | https://www.ncbi.nlm.nih.gov/pubmed/1599240 | http://www.certisusa.com/pdf-labels/Kocide3000_label.pdf | http://www.pesticideinfo.org/Detail_Chemical.jsp?Rec_Id=PC33524https://www.ncbi.nlm.nih.gov/pubmed/8556785 | https://www.ncbi.nlm.nih.gov/pubmed/2135524http://www.emdmillipore.com/US/en/product/Copper-di-ammonium-Titriplex-solution,MDA_CHEM-105217https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a84d61a4-8e7f-4be1-aba6-f633b334aafc | http://www.sciencedirect.com/science/article/pii/S0167488912000158http://www.drugfuture.com/chemdata/schweizer-s-reagent.html | http://pubs.acs.org/doi/abs/10.1021/ed062p878?journalCode=jceda8 | http://pubs.acs.org/doi/abs/10.1021/ed019p356
Curator's Comment: description was created based on several sources, including: https://brandt.co/media/3786/09006mnr100_mineral-research_copper-count-n_lbl_2012-12_25g.pdf | https://southernag.com/wp-content/uploads/2014/06/southernag.com_docs_labels_msds_Liq-Copper-Gal.pdf

Tetraamminecopper dihydroxide also known as Schweizer's Reagent dissolves cellulose; used in rayon production.

CNS Activity

Curator's Comment: Cupric ion was shown to cross the blood brain barrier in rats.

Originator

Sources: http://pubs.acs.org/doi/abs/10.1021/ja01512a012Schweizer, J. Prakt. Chem. 72, 109, 344 (1857).
Curator's Comment: http://www.drugfuture.com/chemdata/schweizer-s-reagent.html

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
3.42 µM [Ki]
Target ID: P00450
Gene ID: 1356.0
Gene Symbol: CP
Target Organism: Homo sapiens (Human)
Target ID: Glutathione S-transferase, rat, liver
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Preventing
Cupric glycinate

Approved Use

Indications for use. For beef calves and beef cattle for the prevention of copper deficiency, or when labeled for veterinary prescription use, for the prevention and/or treatment of copper deficiency alone or in association with molybdenum toxicity.
Primary
COPPER•MAX

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Preventing
COPPER

Approved Use

Copper 0.4 mg/mL (Cupric Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Preventing
COPINOX

Approved Use

Copinox 4g is indicated for the prevention and treatment of copper deficiency in cattle and sheep.
PubMed

PubMed

TitleDatePubMed
Determination of protein by the biuret reaction using cupric hydroxide suspension reagent.
1960
Efficacy of burning, tillage, and biocides in controlling bacteria released at field sites and effects on indigenous bacteria and fungi.
1992 Apr
The effect of various fluoride compounds on the development of experimental root surface caries in hamsters.
1995 Dec
The genetics of tasting in mice. VII. Glycine revisited, and the chromosomal location of Sac and Soa.
1995 Oct
Copper Fluoride Luminescence during UV Photofragmentation of Bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato)copper(II) in the Gas Phase.
1996 Aug 14
Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers.
2000 Jul
The effectiveness of ecologically acceptable ways of protection of field-grown tomato (Lycopersicon lycopersicum (L.) Karsten) from tomato late blight (Phytophthora infestans (Mont.) de Bary) in extreme weather conditions.
2001
Direct catalytic aldol-type reactions using RCH2CN.
2003 Aug 21
Antioxidant activity of olive pulp and olive oil phenolic compounds of the arbequina cultivar.
2005 Mar 23
Cu(II) acetate- and Mn(III) acetate-mediated radical reactions of [60]fullerene with ketonic compounds.
2005 Mar 7
X-ray absorption spectroscopy study of a copper-containing material after thermal treatment.
2006 Apr 17
Acute copper toxicity following copper glycinate injection.
2006 Nov
A spectroscopic and thermoanalytical study of the mineral hoganite.
2007 May
Enhanced copper release from pipes by alternating stagnation and flow events.
2007 Nov 1
Bioavailability of copper from copper glycinate in steers fed high dietary sulfur and molybdenum.
2008 Jan
Synthesis and structural investigation of mono- and polynuclear copper complexes of 4-ethyl-1-(pyridin-2-yl) thiosemicarbazide.
2008 Nov 1
Copper(II) acetate-catalyzed addition of arylboronic acids to aromatic aldehydes.
2009 Jan 16
Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells.
2009 Oct
Generation of oxidant response to copper and iron nanoparticles and salts: Stimulation by ascorbate.
2009 Oct 30
Insight in the transport behavior of copper glycinate complexes through the porcine gastrointestinal membrane using an Ussing chamber assisted by mass spectrometry analysis.
2010 Apr
Copper-promoted coupling of vinyl boronates and alcohols: a mild synthesis of allyl vinyl ethers.
2010 Feb 3
Zinc prevents the copper-induced damage of cultured astrocytes.
2010 Oct
Anti-ovulatory activity of H2 receptor blockers in albino rabbits--a preliminary study.
2011 Apr
Rapid free chlorine decay in the presence of Cu(OH)2: chemistry and practical implications.
2011 Oct 15
Expeditious synthesis of phenanthrenes via CuBr2-catalyzed coupling of terminal alkynes and N-tosylhydrazones derived from o-formyl biphenyls.
2011 Oct 7
Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles.
2012 Apr
Protective effect of sulphoraphane against oxidative stress mediated toxicity induced by CuO nanoparticles in mouse embryonic fibroblasts BALB 3T3.
2012 Feb
CuBr2--a new multiferroic material with high critical temperature.
2012 May 8
Evaluation of topically applied copper(II) oxide nanoparticle cytotoxicity in human skin organ culture.
2013 Feb
Probing the chemical nature of dihydrogen complexation to transition metals, a gas phase case study: H2-CuF.
2013 Jan 18
Design, synthesis, antioxidant, and anti-breast cancer activities of novel diethyl(alkyl/aryl/heteroarylamino)(4-(pyridin-2-yl)phenyl)methylphosphonates.
2013 May
Molecular responses of mouse macrophages to copper and copper oxide nanoparticles inferred from proteomic analyses.
2013 Nov
Cytotoxicity in the age of nano: the role of fourth period transition metal oxide nanoparticle physicochemical properties.
2013 Nov 25
The modality of cell-particle interactions drives the toxicity of nanosized CuO and TiO₂ in human alveolar epithelial cells.
2013 Oct 24
Interference of CuO nanoparticles with metal homeostasis in hepatocytes under sub-toxic conditions.
2014
Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.
2014 Feb 26
Electron induced surface reactions of organometallic metal(hfac)₂ precursors and deposit purification.
2014 Jun 11
CuO nanoparticles induce apoptosis by impairing the antioxidant defense and detoxification systems in the mouse hippocampal HT22 cell line: protective effect of crocetin.
2015 Jun
A Facile Strategy for Catalyst Separation and Recycling Suitable for ATRP of Hydrophilic Monomers Using a Macroligand.
2016 Jan
Dissecting copper homeostasis in diabetes mellitus.
2017 Apr
Unusual 4-arsonoanilinium cationic species in the hydrochloride salt of (4-aminophenyl)arsonic acid and formed in the reaction of the acid with copper(II) sulfate, copper(II) chloride and cadmium chloride.
2017 Apr 1
Comparison of the efficacy of a commercial footbath product with copper sulfate for the control of digital dermatitis.
2017 Jul
Ultrasonic energy enhanced the efficiency of advance extraction methodology for enrichment of trace level of copper in serum samples of patients having neurological disorders.
2017 Jul
Amino acid-mediated 'turn-off/turn-on' nanozyme activity of gold nanoclusters for sensitive and selective detection of copper ions and histidine.
2017 Jun 15
Effects of Excess Copper Ions on Decidualization of Human Endometrial Stromal Cells.
2017 May
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Veterinary drug
Administer ONLY by subcutaneous (under the skin) injection. These doses may be repeated at a minimum period of every 4 months. Dosage may be increased to 4mL in cattle only when either clinical signs or laboratory testing has confirmed copper deficiency is severe. Cattle over 4 months 2mL (0.5 mg calcium copper edetate) Adult Sheep 1mL (0.25 mg calcium copper edetate) Deer 1mL (0.25 mg calcium copper edetate) per 50kg bodyweight
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Wed Jul 05 22:35:15 UTC 2023
Edited
by admin
on Wed Jul 05 22:35:15 UTC 2023
Record UNII
RV823G6G67
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COPPER GLUCONATE
FCC   HSDB   INCI   MART.   USP   VANDF   WHO-DD  
INCI  
Official Name English
CUPRUM GLUCONICUM
Common Name English
CUPRIC GLUCONATE [VANDF]
Common Name English
GLUCONIC ACID, COPPER(2+) SALT (2:1), D-
Common Name English
COPPER GLUCONATE [VANDF]
Common Name English
COPPER GLUCONATE [MART.]
Common Name English
CUPRIC GLUCONATE [MI]
Common Name English
COPPER (AS GLUCONATE)
Common Name English
GLUCONIC ACID, COPPER(2+) SALT
Common Name English
COPPER(II) GLUCONATE
Common Name English
COPPER(II)GLUCONATE
Common Name English
COPPER GLUCONATE [FCC]
Common Name English
COPPER GLUCONATE [USP MONOGRAPH]
Common Name English
COPPER GLUCONATE [INCI]
Common Name English
COPPER, BIS (D-GLUCONATO-O(SUP 1),O(SUP 2))-
Common Name English
COPPER D-GLUCONATE (1:2)
Common Name English
Copper gluconate [WHO-DD]
Common Name English
CUPRIC GLUCONATE
MI   VANDF  
Common Name English
COPPER(2+) D-GLUCONATE, (1:2)
Common Name English
COPPER GLUCONATE [HSDB]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 184.1260
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
FDA ORPHAN DRUG 522516
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
Code System Code Type Description
EVMPD
SUB13457MIG
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
FDA UNII
RV823G6G67
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
MERCK INDEX
M3900
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID4035960
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
RXCUI
2839
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY RxNorm
NCI_THESAURUS
C1505
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
CONCEPT Dietary Supplement
SMS_ID
100000092221
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
HSDB
261
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
DRUG BANK
DB11246
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
PUBCHEM
10692
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
CAS
527-09-3
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
ECHA (EC/EINECS)
208-408-2
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
DAILYMED
RV823G6G67
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
NCI_THESAURUS
C80050
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
WIKIPEDIA
COPPER GLUCONATE
Created by admin on Wed Jul 05 22:35:15 UTC 2023 , Edited by admin on Wed Jul 05 22:35:15 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY